Found: 218
Select item for more details and to access through your institution.
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 9, p. 1628, doi. 10.1093/neuonc/noae058
- By:
- Publication type:
- Article
Clinical pharmacokinetics and pharmacodynamics of ivosidenib, an oral, targeted inhibitor of mutant IDH1, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 433, doi. 10.1007/s10637-019-00771-x
- By:
- Publication type:
- Article
Radiographic prediction of meningioma grade by semantic and radiomic features.
- Published in:
- PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0187908
- By:
- Publication type:
- Article
Handbook of Brain Tumor Chemotherapy.
- Published in:
- 2006
- By:
- Publication type:
- Book Review
Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy -- detecting illusive disease, defining response.
- Published in:
- Frontiers in Neurology, 2015, v. 6, p. 1, doi. 10.3389/fneur.2015.00033
- By:
- Publication type:
- Article
Updated Response Assessment in Neuro-Oncology (RANO) for Gliomas.
- Published in:
- Current Neurology & Neuroscience Reports, 2024, v. 24, n. 2, p. 17, doi. 10.1007/s11910-023-01329-4
- By:
- Publication type:
- Article
Molecular Profiling and Targeted Therapies in Gliomas.
- Published in:
- Current Neurology & Neuroscience Reports, 2023, v. 23, n. 10, p. 627, doi. 10.1007/s11910-023-01299-7
- By:
- Publication type:
- Article
Medical and Neurological Management of Brain Tumor Complications.
- Published in:
- Current Neurology & Neuroscience Reports, 2021, v. 21, n. 10, p. 1, doi. 10.1007/s11910-021-01142-x
- By:
- Publication type:
- Article
Neurologic Complications of Cranial Radiation Therapy and Strategies to Prevent or Reduce Radiation Toxicity.
- Published in:
- Current Neurology & Neuroscience Reports, 2020, v. 20, n. 8, p. 1, doi. 10.1007/s11910-020-01051-5
- By:
- Publication type:
- Article
Novel Therapies for Glioblastoma.
- Published in:
- Current Neurology & Neuroscience Reports, 2020, v. 20, n. 7, p. 1, doi. 10.1007/s11910-020-01042-6
- By:
- Publication type:
- Article
5-[<sup>125</sup>I]Iodo-2'-Deoxyuridine in the Radiotherapy of Brain Tumors in Rats.
- Published in:
- Journal of Nuclear Medicine, 1998, v. 39, n. 7, p. 1148
- By:
- Publication type:
- Article
Intrathecal 5-[<sup>125</sup>I]Iodo-2'-Deoxyuridine in a Rat Model of Leptomeningeal Metastases.
- Published in:
- Journal of Nuclear Medicine, 1997, v. 38, n. 3, p. 386
- By:
- Publication type:
- Article
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 165, n. 1, p. 101, doi. 10.1007/s11060-023-04456-7
- By:
- Publication type:
- Article
Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 158, n. 1, p. 111, doi. 10.1007/s11060-022-04016-5
- By:
- Publication type:
- Article
DICER1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 157, n. 3, p. 499, doi. 10.1007/s11060-022-03994-w
- By:
- Publication type:
- Article
Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 152, n. 3, p. 515, doi. 10.1007/s11060-021-03719-5
- By:
- Publication type:
- Article
Fertility preservation outcomes in women with gliomas: a retrospective case–control study.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 147, n. 2, p. 371, doi. 10.1007/s11060-020-03429-4
- By:
- Publication type:
- Article
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 146, n. 1, p. 79, doi. 10.1007/s11060-019-03337-2
- By:
- Publication type:
- Article
Local control after brain-directed radiation in patients with cystic versus solid brain metastases.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 142, n. 2, p. 355, doi. 10.1007/s11060-019-03106-1
- By:
- Publication type:
- Article
Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 142, n. 1, p. 69, doi. 10.1007/s11060-018-03063-1
- By:
- Publication type:
- Article
Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survival.
- Published in:
- Acta Neuropathologica, 2023, v. 146, n. 4, p. 647, doi. 10.1007/s00401-023-02617-6
- By:
- Publication type:
- Article
The 1p-Encoded Protein Stathmin and Resistance of Malignant Gliomas to Nitrosoureas.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 8, p. 639, doi. 10.1093/jnci/djk135
- By:
- Publication type:
- Article
The predictive value of partial MGMT promoter methylation for IDH-wild-type glioblastoma patients.
- Published in:
- Neuro-Oncology Practice, 2023, v. 10, n. 2, p. 126, doi. 10.1093/nop/npac070
- By:
- Publication type:
- Article
Frequency, etiologies, risk factors, and sequelae of falls among patients with brain metastases: A population- and institutional-level analysis.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 2, p. 114, doi. 10.1093/nop/npab061
- By:
- Publication type:
- Article
Emergency department visits and inpatient hospitalizations among older patients with brain metastases: a dual population- and institution-level analysis.
- Published in:
- Neuro-Oncology Practice, 2021, v. 8, n. 5, p. 569, doi. 10.1093/nop/npab029
- By:
- Publication type:
- Article
Provider-reported challenges and barriers to referring patients to neuro-oncology clinical trials: a report from the Society for Neuro-Oncology member survey.
- Published in:
- Neuro-Oncology Practice, 2020, v. 7, n. 1, p. 38, doi. 10.1093/nop/npz038
- By:
- Publication type:
- Article
Response Assessment in Neuro-Oncology (RANO): more than imaging criteria for malignant glioma.
- Published in:
- Neuro-Oncology Practice, 2015, v. 2, n. 4, p. 205, doi. 10.1093/nop/npv037
- By:
- Publication type:
- Article
Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinoma.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00304-5
- By:
- Publication type:
- Article
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-03905-6
- By:
- Publication type:
- Article
Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 11, p. 1161, doi. 10.1038/nbt.3697
- By:
- Publication type:
- Article
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline.
- Published in:
- British Journal of Haematology, 2009, v. 144, n. 6, p. 895, doi. 10.1111/j.1365-2141.2008.07573.x
- By:
- Publication type:
- Article
Low Incidence of Pseudoprogression by Imaging in Newly Diagnosed Glioblastoma Patients Treated With Cediranib in Combination With Chemoradiation.
- Published in:
- Oncologist, 2014, v. 19, n. 1, p. 75, doi. 10.1634/theoncologist.2013-0101
- By:
- Publication type:
- Article
Discontinuing Bevacizumab in Patients with Glioblastoma: An Ethical Analysis.
- Published in:
- Oncologist, 2011, v. 16, n. 10, p. 1435, doi. 10.1634/theoncologist.2011-0047
- By:
- Publication type:
- Article
Corticosteroid Use in Patients with Glioblastoma at First or Second Relapse Treated with Bevacizumab in the BRAIN Study.
- Published in:
- Oncologist, 2010, v. 15, n. 12, p. 1329, doi. 10.1634/theoncologist.2010-0105
- By:
- Publication type:
- Article
Intravascular lymphomatosis and intracerebral haemorrhage.
- Published in:
- Neurological Sciences, 2010, v. 31, n. 6, p. 793, doi. 10.1007/s10072-010-0284-7
- By:
- Publication type:
- Article
Phase II trial of ponatinib in patients with bevacizumab‐refractory glioblastoma.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 13, p. 5988, doi. 10.1002/cam4.2505
- By:
- Publication type:
- Article
DNA Fragmentation Simulation Method (FSM) and Fragment Size Matching Improve aCGH Performance of FFPE Tissues.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0038881
- By:
- Publication type:
- Article
Migraine With Aura as the Presentation of Leukemia.
- Published in:
- Headache: The Journal of Head & Face Pain, 1995, v. 35, n. 9, p. 560, doi. 10.1111/j.1526-4610.1995.hed3509560.x
- By:
- Publication type:
- Article
NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Challenges with defining response to antitumor agents in pediatric neuro-oncology: A report from the response assessment in pediatric neuro-oncology (RAPNO) working group.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 9, p. 1397, doi. 10.1002/pbc.24562
- By:
- Publication type:
- Article
The design and evaluation of hybrid controlled trials that leverage external data and randomization.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33192-1
- By:
- Publication type:
- Article
Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32430-w
- By:
- Publication type:
- Article
Imaging in neuro-oncology.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418759865
- By:
- Publication type:
- Article
Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Extent of resection and overall survival for patients with atypical and malignant meningioma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 7, p. 997, doi. 10.1002/cncr.28935
- By:
- Publication type:
- Article
Recurrent glioblastoma: Volumetric assessment and stratification of patient survival with early posttreatment magnetic resonance imaging in patients treated with bevacizumab.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 19, p. 3479, doi. 10.1002/cncr.28210
- By:
- Publication type:
- Article
Signal transduction inhibitors and antiangiogenic therapies for malignant glioma.
- Published in:
- Glia, 2011, v. 59, n. 8, p. 1205, doi. 10.1002/glia.21137
- By:
- Publication type:
- Article